SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-05-225000
Filing Date
2005-11-14
Accepted
2005-11-14 10:37:21
Documents
5
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 216001
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9001
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9028
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3345
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3393
  Complete submission text file 0001193125-05-225000.txt   242261
Mailing Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277
Business Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51462 | Film No.: 051197669
SIC: 2836 Biological Products, (No Diagnostic Substances)